Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

Journal of Clinical Oncology

Volumn 19, Issue 5, 2001, Pages 1350-1357

  Ma, J ^a   Mai, H Q ^a   Hong, M H ^a   Min, H Q ^a   Mao, Z D ^a   Cui, N J ^a   Lu, T X ^a   Mo, H Y ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035282127     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.5.1350     Document Type: Article

References (34)

1. Carcinoma of the nasopharynx: Factors affecting prognosis
2. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients
3. Analysis of 1379 patients with nasopharyngeal carcinoma
4. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure
5. Nasopharyngeal carcinoma
6. A new staging system for nasopharyngeal carcinoma in China
7. A comparison of Ho's, International Union Against Cancer, and American Joint Committee Stage Classifications for nasopharyngeal carcinoma
8. A clinical verification of Chinese 1992 staging system for nasopharyngeal carcinoma
9. Chemotherapy for nasopharyngeal carcinoma: A ten-year experience
10. Chemotherapeutic management of head and neck cancer
11. Phase II study of combination carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma
12. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin and fluorouracil
13. Metastatic undifferentiated carcinoma of nasopharyngeal type treated with bleomycin (B), epirubicin (E), and cisplatin (C): Final report
14. 5-Fluorouracil (FU), mitomycin (M), epirubicin (E), cisplatin (P) in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma (UCNT)
15. Undifferentiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspects
16. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: A Radiation Therapy Oncology Group study
17. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
18. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma
19. Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx
20. Sequential chemotherapy and radiation for nasopharyngeal cancer: Absence of long-term benefit despite a high rate of tumor response to chemotherapy
21. A study on improving the treatment technique of the radiotherapy in nasopharyngeal carcinoma: Part I. The dose distribution of target volume
22. A study on improving the treatment technique of the radiotherapy in nasopharyngeal carcinoma: Part II. Clinical results
23. Nasopharyngeal carcinoma: The Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy
24. Nasopharyngeal carcinoma: Result of treatment with cis-diamminedichloro-platinum II, 5 fluorouracil, and radiotherapy
25. Reporting results of cancer treatment
26. Nonparametric estimation from incomplete observations
27. International Nasopharynx Cancer Study Group: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
28. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
29. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy
30. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study
31. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
32. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
33. The role of chemotherapy in the management of nasopharyngeal carcinoma
34. Concurrent chemotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: Toxicities and preliminary results